JENNIFER SPRIGGS: Open Payments
NPI 1255648671 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 39 payments from 18 companies in 2025. Trend: 2023 $689 · 2024 $770 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $204 |
| Janssen Biotech, Inc. | 4 | $86 |
| Novo Nordisk Inc | 4 | $75 |
| Amgen Inc. | 4 | $70 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $46 |
| Astellas Pharma US Inc | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| QOL Medical, LLC | 1 | $27 |
Products named: Assure WCD, TREMFYA, Wegovy, OTEZLA, LifeVest, LEQVIO, BREZTRI, Veozah.
Industry payments across KS — which companies pay providers there.
